Evotec Q1 Adj. EBITDA Down

Evotec SE (EVTCY.PK,EVOTF.PK), a German drug discovery alliance and development partnership company, Tuesday reported that its first-quarter adjusted Group EBITDA declined to 21.1 million euros from last year's 30.0 million euros, affected by the anticipated end of the Sanofi payment and unfavorable fx effects

Group revenues from contracts with customers increased by 11 percent to 133.1 million euros. EVT Execute revenue was up 16 percent to 136.9 million euros, and EVT Innovate revenue rose 21 percent to 28.2 million euros.

Looking ahead to the full year, the Group expects revenues to be in the range of 550 - 570 million euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hedge-fund billionaire William Ackman's Pershing Square Tontine Holdings Ltd. (PSTH) agreed to acquire 10% of Universal Music Group from French media conglomerate Vivendi (VIV.L, VIVEF.PK) for about $4 billion, the companies said in a statement on Sunday. The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings.
Follow RTT